Pure Global

LZI Benzodiazepine EIA Kit - Taiwan Registration 797ec4a7ebab2ff12be5c743a7bf7b6b

Access comprehensive regulatory information for LZI Benzodiazepine EIA Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 797ec4a7ebab2ff12be5c743a7bf7b6b and manufactured by LIN-ZHI INTERNATIONAL, INC. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
797ec4a7ebab2ff12be5c743a7bf7b6b
Registration Details
Taiwan FDA Registration: 797ec4a7ebab2ff12be5c743a7bf7b6b
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

LZI Benzodiazepine EIA Kit
TW: ้ˆ่Š่‹ฏไบŒๆฐฎ้…ต็ด ๅ…็–ซ่ฉฆๅŠ‘
Risk Class 2
MD

Registration Details

797ec4a7ebab2ff12be5c743a7bf7b6b

Ministry of Health Medical Device Import No. 031767

DHA05603176700

Company Information

United States

Product Details

This product is used for the qualitative and semi-quantitative determination of benzodiazepine content in human urine, with a threshold of 200ng/mL or 300ng/mL.

A Clinical chemistry and clinical toxicology

A3170 Benzene (para)dinitrogen test system

Imported from abroad

Dates and Status

Oct 31, 2018

Oct 31, 2023